ACCENDRA HEALTH INC/VA/

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $9.7b $9.3b $9.8b $9.2b $8.5b $9.8b $10.0b $10.3b $10.7b $2.8b
Cost of Goods and Services Sold $8.5b $8.1b $8.5b $8.1b $7.2b $8.3b $8.1b $8.2b $8.5b $1.5b
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization $1.3b
Gross Profit (derived) $1.2b $1.2b $1.4b $1.1b $1.3b $1.5b $1.8b $2.1b $2.2b $1.3b
Operating Costs and Expenses $2.4b $2.9b $2.7b
Operating Income (Loss) $199.6m $89.3m ($392.2m) $73.2m $204.1m $368.5m $142.9m $104.5m ($207.8m) $27.5m
Additional Financial Items
Amortization of Intangible Assets $10.0m $16.4m $36.5m $44.0m $41.5m $39.8m $78.8m $83.5m $64.9m $74.0m
Capitalized Computer Software, Amortization $12.9m $10.7m $12.8m $9.3m $10.2m $10.3m $14.0m $16.1m $17.0m
Goodwill, Impairment Loss $0 $423.1m $0 $0 $307.1m $0
Income (Loss) from Continuing Operations before Income Taxes, Domestic $150.9m $49.9m ($420.0m) ($33.0m) $80.6m $231.4m ($17.6m) ($65.4m) ($383.5m) ($104.1m)
Income (Loss) from Continuing Operations, Per Basic Share ($0) $1 $3 $0 ($1) ($5) ($1)
Income (Loss) from Continuing Operations, Per Diluted Share ($0) $1 $3 $0 ($1) ($5) ($1)
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic $297k $58k $0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $28.7m $109.9m $276.8m $10.9m ($54.7m) ($357.4m) ($102.0m)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($22.6m) $88.1m $221.6m $22.4m $8.9m $350.7m ($102.7m)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $8.9m $350.7m ($102.7m)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $8.9m $350.7m ($998.0m)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent ($39.8m) ($58.2m) $0 $0 $8.9m $350.7m ($998.0m)
Net Income (Loss) Attributable to Parent $108.8m $72.8m ($437.0m) ($62.4m) $29.9m $221.6m $22.4m ($41.3m) ($362.7m) ($1.1b)
Net Income (Loss) Available to Common Stockholders, Basic $107.6m $71.7m ($437.0m) ($1) $0 $3 $0 ($1) ($5) ($14)
Earnings Per Share, Basic $1.76 $1.03 $0.86 ($1.03) $0.47 $3.05 $0.30 ($0.54) ($4.73) ($14.31)
Earnings Per Share, Diluted $1.76 $1.20 ($7.28) ($1.03) $0.47 $2.94 $0.29 ($0.54) ($4.73) ($14.31)
Common Stock, Dividends, Per Share, Declared $1.02 $1.03 $0.86 $0.01 $0.01 $0.01 $0.29 ($0.54) ($4.73) ($14.31)
Weighted Average Number of Shares Outstanding, Basic 61.1m 60.0m 63.4m 72.7m 74.5m 75.8m 76.7m 76.9m
Weighted Average Number of Shares Outstanding, Diluted 61.1m 60.0m 63.5m 75.5m 76.2m 75.8m 76.7m 76.9m
Selling, General and Administrative Expense $970.4m $1.0b $1.3b $1.0b $1.0b $1.1b $1.6b $1.8b $1.9b $1.1b
Other Nonoperating Income (Expense) ($3.8m)
Interest Expense (non-operating) $107.2m
Business Combination, Acquisition Related Costs $17.3m $45.3m $15.7m $17.5m $22.0m $22.0m
Current Income Tax Expense (Benefit) $59.5m $34.7m $2.8m $11.3m $6.3m $84.9m $14.9m $10.3m $31.4m $18.6m
Interest Expense $27.1m $31.8m $77.0m $98.1m $83.4m $48.1m $128.9m $157.9m $143.8m $107.2m
Nonoperating Income (Expense) ($3.8m) ($10.8m) ($3.2m) ($3.1m) ($4.8m) ($4.7m) ($3.9m)
Other Cost of Operating Revenue $22.6m
Research and Development Expense $13.2m $13.0m
Restructuring and Related Cost, Incurred Cost $11.9m $26.1m $6.7m $10.6m $11.2m
Income Tax Expense (Benefit) $63.8m ($15.3m) ($32.2m) ($6.1m) $21.8m $55.2m ($11.5m) ($13.4m) $5.3m $729k
Other Operating Income (Expense), Net $7.4m ($4.9m) $4.4m ($2.2m) $2.4m $6.2m $5.3m ($6.9m) ($13.3m) $27.5m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.